Post by
skibumm on Oct 04, 2020 10:04pm
Vivo doing all the right things...but clearly a 2021 story
lots of griping & complaining about the stock price, but face the facts. Vivo just diluted shareholder value 10% to partially settle debenture due...now has 328+M shares outstanding...and Laflamme owns a ton of them that he can dump on the market any time he wants. Vivo is still not profitable...no German licence...and Fishman has lots of other problems to deal with, one at a time. There is 50/50 chance imo that Vivo emerges as a winner in 2021...but I have a full position so I am banking on Fishman to deliver for the shareholders......1 thing Vivo did right is loan to CB2 Insite cbii/c, that was converted to 6.2M shares app .03....now valued at .24 and company showing lots of potential with telemed in US
Comment by
LI4VESTREAM543 on Oct 05, 2020 12:39am
This post has been removed in accordance with Community Policy